Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000031001Phase 4Not yet recruiting
Phase 4, open-label trial of dexmedetomidine (2 arms), sponsored by Beijing Friendship Hospital. Primary endpoints: Somatosensory evoked potential amplitude, Somatosensory evoked potential latency and 2 more. Planned start Apr 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000031001.